These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 12215250)

  • 41. NSGC practice guideline: risk assessment and genetic counseling for hereditary breast and ovarian cancer.
    Berliner JL; Fay AM; Cummings SA; Burnett B; Tillmanns T
    J Genet Couns; 2013 Apr; 22(2):155-63. PubMed ID: 23188549
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Patients' attitudes about autonomy and confidentiality in genetic testing for breast-ovarian cancer susceptibility.
    Benkendorf JL; Reutenauer JE; Hughes CA; Eads N; Willison J; Powers M; Lerman C
    Am J Med Genet; 1997 Dec; 73(3):296-303. PubMed ID: 9415688
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The choice is yours? How women with ovarian cancer make sense of treatment choices.
    Ziebland S; Evans J; McPherson A
    Patient Educ Couns; 2006 Sep; 62(3):361-7. PubMed ID: 16876377
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Primary care physician referral practices regarding BRCA1/2 genetic counseling in a major health system.
    Linfield DT; Rothberg MB; Pfoh ER; Noss R; Cassard L; Powers JC; Lipold L; Martinez KA
    Breast Cancer Res Treat; 2022 Sep; 195(2):153-160. PubMed ID: 35842521
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Decision making with uncertain information: learning from women in a high risk breast cancer clinic.
    Frost CJ; Venne V; Cunningham D; Gerritsen-McKane R
    J Genet Couns; 2004 Jun; 13(3):221-36. PubMed ID: 15604633
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genetic counseling and testing for breast-ovarian cancer susceptibility: what do women want?
    Audrain J; Rimer B; Cella D; Garber J; Peshkin BN; Ellis J; Schildkraut J; Stefanek M; Vogel V; Lerman C
    J Clin Oncol; 1998 Jan; 16(1):133-8. PubMed ID: 9440734
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Low rates of African American participation in genetic counseling and testing for BRCA1/2 mutations: racial disparities or just a difference?
    Halbert CH; Kessler L; Collier A; Weathers B; Stopfer J; Domchek S; McDonald JA
    J Genet Couns; 2012 Oct; 21(5):676-83. PubMed ID: 22790832
    [TBL] [Abstract][Full Text] [Related]  

  • 48. What do women really want to know? Motives for attending familial breast cancer clinics.
    Van Asperen CJ; Van Dijk S; Zoeteweij MW; Timmermans DR; De Bock GH; Meijers-Heijboer EJ; Niermeijer MF; Breuning MH; Kievit J; Otten W
    J Med Genet; 2002 Jun; 39(6):410-4. PubMed ID: 12070250
    [No Abstract]   [Full Text] [Related]  

  • 49. Concordance with BRCA1/2 testing guidelines among women in The Health of Women (HOW) Study
    Silver MI; Klein W; Samimi G; Minasian L; Loud J; Roberts MC
    Breast Cancer Res Treat; 2019 Feb; 173(3):719-726. PubMed ID: 30413980
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Telephone genetic counseling for high-risk women undergoing BRCA1 and BRCA2 testing: rationale and development of a randomized controlled trial.
    Peshkin BN; Demarco TA; Graves KD; Brown K; Nusbaum RH; Moglia D; Forman A; Valdimarsdottir H; Schwartz MD
    Genet Test; 2008 Mar; 12(1):37-52. PubMed ID: 18373403
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Moving into the mainstream: healthcare professionals' views of implementing treatment focussed genetic testing in breast cancer care.
    Hallowell N; Wright S; Stirling D; Gourley C; Young O; Porteous M
    Fam Cancer; 2019 Jul; 18(3):293-301. PubMed ID: 30689103
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Motivations and concerns of women considering genetic testing for breast cancer: a comparison between affected and at-risk probands.
    Brandt R; Hartmann E; Ali Z; Tucci R; Gilman P
    Genet Test; 2002; 6(3):203-5. PubMed ID: 12490060
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Experiences of genetic counseling for BRCA1/2 among recently diagnosed breast cancer patients: a qualitative inquiry.
    Vadaparampil ST; Quinn GP; Brzosowicz J; Miree CA
    J Psychosoc Oncol; 2008; 26(4):33-52. PubMed ID: 19042271
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Determinants of preferences for genetic counselling in Jewish women.
    Apicella C; Peacock SJ; Andrews L; Tucker K; Bankier A; Daly MB; Hopper JL
    Fam Cancer; 2006; 5(2):159-67. PubMed ID: 16736286
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Balancing autonomy and responsibility: the ethics of generating and disclosing genetic information.
    Hallowell N; Foster C; Eeles R; Ardern-Jones A; Murday V; Watson M
    J Med Ethics; 2003 Apr; 29(2):74-9; discussion 80-3. PubMed ID: 12672886
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The process of deciding about prophylactic surgery for breast and ovarian cancer: Patient questions, uncertainties, and communication.
    Klitzman R; Chung W
    Am J Med Genet A; 2010 Jan; 152A(1):52-66. PubMed ID: 20014126
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Providers' perceptions and practices regarding BRCA1/2 genetic counseling and testing in African American women.
    Graves KD; Christopher J; Harrison TM; Peshkin BN; Isaacs C; Sheppard VB
    J Genet Couns; 2011 Dec; 20(6):674-89. PubMed ID: 21822773
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Why should primary care physicians know about breast cancer genetics?
    Pinsky LE; Culver JB; Hull J; Levy-Lahad E; Daly M; Burke W
    West J Med; 2001 Sep; 175(3):168-73. PubMed ID: 11527843
    [No Abstract]   [Full Text] [Related]  

  • 59. What PAs should know before they refer patients to a genetic counselor.
    Gordon E
    JAAPA; 2009 Sep; 22(9):61-3. PubMed ID: 19827402
    [No Abstract]   [Full Text] [Related]  

  • 60. Communication of BRCA1 and BRCA2 genetic test results to health care providers following genetic testing at a tertiary care center.
    Ready K; Arun BK; Schmeler KM; Uyei A; Litton JK; Lu KH; Sun CC; Peterson SK
    Fam Cancer; 2011 Dec; 10(4):673-9. PubMed ID: 21681553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.